Calico Labs

San Francisco, United States Founded: 2013 • Age: 13 yrs Acquired By Abcam
Age-related disorders are addressed through senescent biology research.

About Calico Labs

Calico Labs is a company based in San Francisco (United States) founded in 2013 by Arthur Levinson was acquired by Abcam in January 2019.. Calico Labs offers products and services including Drug Development Services and Research and Technology Platforms. Calico Labs operates in a competitive market with competitors including Nuvalent, Enliven Therapeutics, Nura Bio, Actym Therapeutics and Abbisko Therapeutics, among others.

  • Headquarter San Francisco, United States
  • Founders Arthur Levinson
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Calico Life Sciences Llc
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Abcam

    (Jan 28, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Calico Labs

Calico Labs offers a comprehensive portfolio of products and services, including Drug Development Services and Research and Technology Platforms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops interventions for age-related diseases through research

Conducts studies on aging biology and related technologies

People of Calico Labs
Headcount 10-50
Employee Profiles 120
Board Members and Advisors 4
Employee Profiles
People
Cynthia Kenyon
Vice President, Aging Research
People
Arthur Levinson
Founder & CEO
People
Jonathan W. Lewis
Chief Business Officer
People
Magdalena Lopez
Director, Cellular Models & Assay Technologies

Unlock access to complete

Board Members and Advisors
people
Jonathan Pritchard
Advisor

Unlock access to complete

Funding Insights of Calico Labs

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Calico Labs

Calico Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abcam. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Biological reagents and antibodies are developed for life science research.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Calico Labs

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Calico Labs

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Calico Labs Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Calico Labs

Calico Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuvalent, Enliven Therapeutics, Nura Bio, Actym Therapeutics and Abbisko Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic solutions for cancer, including NSCLC inhibitors, are developed.
domain founded_year HQ Location
Developer of drugs for solid tumours and blood cancers
domain founded_year HQ Location
Diagnostic solutions and neuroprotective medicines for neurological disorders are provided.
domain founded_year HQ Location
Immune therapy systems are developed for therapeutic applications.
domain founded_year HQ Location
Developing novel small molecule drugs for immunomodulatory pathways to treat cancer
domain founded_year HQ Location
RNA-modifying drug candidates are developed for multiple disorders.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Calico Labs

Frequently Asked Questions about Calico Labs

When was Calico Labs founded?

Calico Labs was founded in 2013.

Where is Calico Labs located?

Calico Labs is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Who is the current CEO of Calico Labs?

Arthur Levinson is the current CEO of Calico Labs. They have also founded this company.

What does Calico Labs do?

Calico Labs was established in 2013 as a Google spin-out under Alphabet, with operations based in San Francisco, United States. Focus is placed on biotechnology research targeting senescent biology to prevent and treat age-related diseases. A small molecule drug has been licensed from UCSF to inhibit eLF2 alpha inactivation in the unfolded protein response pathway. Leadership is provided by Arthur Levinson, former CEO of Genentech.

Who are the top competitors of Calico Labs?

Calico Labs's top competitors include Nuvalent, Enliven Therapeutics and Abbisko Therapeutics.

What products or services does Calico Labs offer?

Calico Labs offers Drug Development Services and Research and Technology Platforms.

Who are Calico Labs's investors?

Calico Labs has 1 investor. Key investors include Abcam.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available